Navigation Links
EraGen lands $12 million venture round

Madison, Wis. EraGen Biosciences has gained another $12 million in venture capital in an investment round led by out-of-state firms.

EraGen makes diagnostics products that clinicians and researchers can use to do genetic tests, for example, to determine the suitability of certain drugs to animals or people. The company says it has received $21 million so far in venture investment,......

Full article >>>
'"/>

Source:wistechnology.com By Jason Stitt 01/09/06


Page: 1

Related biology technology :

1. EraGen set to highlight diagnostic products at BIO
2. EraGen diagnostic passes UW tests, could quickly detect bird flu
3. EraGen gets $250,000 state loan to revamp manufacturing facility
4. EraGen strikes big distribution deal; Berbee buys again
5. EraGen cystic fibrosis test to be distributed worldwide through Bayer
6. EraGens SARS test validated by Chinese agency
7. EraGen collaborates with Emory University on HIV detection system
8. EraGen signs Canadian Market Distribution Agreement for nucleic acid dection products
9. Promega and EraGen sign technology licensing agreement
10. EraGens Revolutionary Genomic-Based Technologies
11. EraGen Expands in Japan
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/25/2017)... ... February 25, 2017 , ... The ... in an ongoing effort to create meaningful change by increasing communication, partnerships and ... emphasis on consumers and patients’ mental health well-being. , Both organizations are dedicated ...
(Date:2/24/2017)... DIEGO , Feb. 24, 2017  Aethlon Medical, ... following note authored by its Chairman and CEO, ... at the Munich Security Conference last Saturday, Bill ... virus could kill more people than nuclear weapons. Mr. ... U.S. and U.K. intelligence agencies, that scientific terrorists have ...
(Date:2/24/2017)... China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" ... in China, today announced its financial results for the fourth ... Quarter 2016 Financial Highlights Total sales ... RMB terms, or increased by 13.6% in USD terms to ... 2015. Gross profit increased by 13.3% to ...
(Date:2/23/2017)... ... February 23, 2017 , ... BellBrook ... portfolio to include an array of biochemical analyses critical for Lead Discovery. ... their hit-to-lead and SAR programs, including inhibitor potency and selectivity, mechanism of action, ...
Breaking Biology Technology:
(Date:1/31/2017)... Mass. , Jan. 31, 2017  Spero ... novel therapies for the treatment of bacterial infections, ... set of antibacterial candidates from Pro Bono Bio ... increased prevalence of multi-drug resistant forms of Gram-negative ... Cantab Anti Infectives Ltd, a PBB group company. ...
(Date:1/26/2017)... 26, 2017  Acuity Market Intelligence today released ... Digital Identity".  Acuity characterizes 2017 as a "breakout" ... adoption reflects a new understanding of the potential ... and digital identity are often perceived as threats ... , Principal of Acuity Market intelligence. "However, taken ...
(Date:1/24/2017)... 24, 2017  It sounds simple and harmless—an ... monitors vital signs and alerts parents on their ... saturation level drops. But pediatric experts argue that ... with no evidence of medical benefits, especially to ... aggressively to parents of healthy babies, promising peace ...
Breaking Biology News(10 mins):